Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JQ.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.25.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.16.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.57.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.44.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCWEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.108EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.104EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JE.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.10.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.41.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
LQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used